Symbol="MESO"
AssetType="Common Stock"
Name="Mesoblast Ltd"
Description="Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia."
CIK="1345099"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="691595000"
EBITDA="-67471000"
PERatio="0.361"
PEGRatio="0"
BookValue="3.275"
DividendPerShare="0"
DividendYield="0"
EPS="11.78"
RevenuePerShareTTM="0.055"
ProfitMargin="0"
OperatingMarginTTM="-9.23"
ReturnOnAssetsTTM="-0.0657"
ReturnOnEquityTTM="-0.163"
RevenueTTM="7586000"
GrossProfitTTM="-53361000"
DilutedEPSTTM="11.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="10.5"
TrailingPE="0.361"
ForwardPE="833.33"
PriceToSalesRatioTTM="56.79"
PriceToBookRatio="0.93"
EVToRevenue="62.57"
EVToEBITDA="-7.87"
Beta="2.403"
num_52WeekHigh="4.62"
num_52WeekLow="2.53"
num_50DayMovingAverage="3.685"
num_200DayMovingAverage="3.328"
SharesOutstanding="162732000"
DividendDate="None"
ExDividendDate="None"
symbol="MESO"
open="4.33"
high="4.36"
low="4.15"
price="4.34"
volume="265432.00"
latest_trading_day="2023-07-12"
previous_close="4.08"
change="0.26"
change_percent="6.2424%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="142680"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="605"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
